Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (27729) 27729
Newspaper Article (492) 492
Magazine Article (441) 441
Newsletter (421) 421
Book Chapter (331) 331
Book / eBook (33) 33
Dissertation (32) 32
Publication (20) 20
Conference Proceeding (19) 19
Trade Publication Article (16) 16
Government Document (11) 11
Web Resource (6) 6
Reference (5) 5
Transcript (4) 4
Book Review (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (21455) 21455
female (20950) 20950
science & technology (17885) 17885
life sciences & biomedicine (17221) 17221
middle aged (8762) 8762
estrogen (7401) 7401
biological and medical sciences (6184) 6184
adult (6062) 6062
animals (5768) 5768
estrogens (5684) 5684
medical sciences (5498) 5498
aged (5445) 5445
breast cancer (4799) 4799
risk factors (4737) 4737
male (4487) 4487
menopause (4460) 4460
estrogen replacement therapy - adverse effects (4245) 4245
estrogens - adverse effects (4010) 4010
oncology (3865) 3865
abridged index medicus (3337) 3337
obstetrics & gynecology (3277) 3277
health aspects (2798) 2798
hormone replacement therapy (2543) 2543
breast neoplasms - drug therapy (2538) 2538
pregnancy (2471) 2471
cancer (2449) 2449
research (2435) 2435
postmenopause (2371) 2371
pharmacology. drug treatments (2202) 2202
tumors (2140) 2140
gynecology. andrology. obstetrics (2005) 2005
estrogen replacement therapy (1971) 1971
analysis (1933) 1933
endocrinology & metabolism (1904) 1904
hormones (1880) 1880
care and treatment (1869) 1869
estrogens - therapeutic use (1863) 1863
rats (1846) 1846
hormone therapy (1815) 1815
women (1776) 1776
breast neoplasms - pathology (1775) 1775
treatment outcome (1748) 1748
receptors, estrogen - metabolism (1720) 1720
toxicology (1689) 1689
postmenopausal women (1609) 1609
womens health (1601) 1601
medicine & public health (1591) 1591
time factors (1531) 1531
general & internal medicine (1524) 1524
medicine, general & internal (1494) 1494
estrogens - administration & dosage (1443) 1443
pharmacology & pharmacy (1419) 1419
estradiol (1404) 1404
breast neoplasms - chemically induced (1363) 1363
progesterone (1359) 1359
mice (1355) 1355
phenols (1306) 1306
aged, 80 and over (1302) 1302
osteoporosis (1297) 1297
breast neoplasms - metabolism (1254) 1254
risk assessment (1252) 1252
dose-response relationship, drug (1246) 1246
estrogens - pharmacology (1238) 1238
tamoxifen (1212) 1212
risk (1172) 1172
physiological aspects (1155) 1155
contraceptives, oral - adverse effects (1145) 1145
environmental sciences (1135) 1135
environmental sciences & ecology (1133) 1133
breast neoplasms - epidemiology (1130) 1130
prospective studies (1129) 1129
tamoxifen - therapeutic use (1123) 1123
gene expression (1119) 1119
prognosis (1096) 1096
age factors (1083) 1083
public, environmental & occupational health (1068) 1068
research article (1067) 1067
estrogens - metabolism (1054) 1054
adolescent (1050) 1050
chemotherapy (1044) 1044
drug therapy (1042) 1042
follow-up studies (1020) 1020
randomized controlled trials as topic (1018) 1018
fundamental and applied biological sciences. psychology (1013) 1013
ovariectomy (1005) 1005
mammary gland diseases (1002) 1002
internal medicine (1001) 1001
estrogen replacement therapy - methods (977) 977
tamoxifen - adverse effects (977) 977
clinical trials (958) 958
progestins - adverse effects (953) 953
estrogen receptors (951) 951
estradiol - administration & dosage (944) 944
testosterone (931) 931
double-blind method (927) 927
case-control studies (918) 918
studies (911) 911
women's health (882) 882
medicine (873) 873
estradiol - pharmacology (871) 871
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (28) 28
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
New College (Ivey) - Stacks (4) 4
Online Resources - Online (4) 4
UTL at Downsview - May be requested (2) 2
OISE - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (27661) 27661
German (542) 542
French (516) 516
Japanese (280) 280
Spanish (133) 133
Italian (112) 112
Russian (94) 94
Norwegian (76) 76
Polish (76) 76
Chinese (71) 71
Swedish (70) 70
Danish (63) 63
Portuguese (60) 60
Dutch (49) 49
Czech (40) 40
Hungarian (32) 32
Finnish (30) 30
Bulgarian (29) 29
Hebrew (21) 21
Croatian (7) 7
Romanian (7) 7
Serbian (7) 7
Korean (5) 5
Lithuanian (4) 4
Ukrainian (4) 4
Afrikaans (2) 2
Slovak (2) 2
Turkish (2) 2
Arabic (1) 1
Bosnian (1) 1
Greek (1) 1
Persian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Ischemic Colitis as a Complication of Medication Use: An Analysis of the Federal Adverse Event Reporting System
by Bielefeldt, Klaus
Digestive diseases and sciences, ISSN 0163-2116, 9/2016, Volume 61, Issue 9, pp. 2655 - 2665
Biochemistry, general | Triptans | Treatment complication | Medicine & Public Health | Hepatology | Alosetron | Colonoscopy | Gastroenterology | Oncology | Interferon | Tegaserod | Transplant Surgery | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | United States - epidemiology | Age Factors | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Interferons - adverse effects | Male | Osteoporosis - drug therapy | Estrogens - adverse effects | Colitis, Ischemic - epidemiology | Laxatives - adverse effects | Serotonin Antagonists - adverse effects | Antineoplastic Agents - adverse effects | Female | Diphosphonates - adverse effects | Autoimmune Diseases - drug therapy | Carbolines - adverse effects | Colitis, Ischemic - chemically induced | Databases, Factual | Tryptamines - adverse effects | Bone Density Conservation Agents - adverse effects | Adverse Drug Reaction Reporting Systems | Gonadal Steroid Hormones - adverse effects | Colitis, Ischemic - mortality | Irritable Bowel Syndrome - drug therapy | Anticoagulants - adverse effects | Serotonin Receptor Agonists - adverse effects | Preoperative Care | Serotonin Agents - adverse effects | Neoplasms - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Indoles - adverse effects | Mental Disorders - drug therapy | Sex Factors | Immunosuppressive Agents - adverse effects | Aged | Gastrointestinal agents | Anticoagulants (Medicine) | Biological response modifiers | Drug approval | Chemotherapy | Antipsychotic drugs | Analysis | Irritable bowel syndrome | Health care industry | Hormones, Sex | Colitis | Drug therapy | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
by Gnant, Michael and Mlineritsch, Brigitte and Schippinger, Walter and Luschin-Ebengreuth, Gero and Pöstlberger, Sabine and Menzel, Christian and Jakesz, Raimund and Seifert, Michael and Hubalek, Michael and Bjelic-Radisic, Vesna and Samonigg, Hellmut and Tausch, Christoph and Eidtmann, Holger and Steger, Günther and Kwasny, Werner and Dubsky, Peter and Fridrik, Michael and Fitzal, Florian and Stierer, Michael and Rücklinger, Ernst and Greil, Richard and ABCSG-12 Trial Investigators
The New England journal of medicine, ISSN 0028-4793, 02/2009, Volume 360, Issue 7, pp. 679 - 691
Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | General aspects | Medical sciences | Tumors | Breast Neoplasms - surgery | Triazoles - adverse effects | Follow-Up Studies | Humans | Middle Aged | Receptors, Estrogen - analysis | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Diphosphonates - therapeutic use | Adult | Female | Chemotherapy, Adjuvant | Imidazoles - therapeutic use | Drug Therapy, Combination | Goserelin - therapeutic use | Aromatase Inhibitors - therapeutic use | Diphosphonates - adverse effects | Triazoles - therapeutic use | Bone Density Conservation Agents - adverse effects | Premenopause | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Breast Neoplasms - drug therapy | Disease-Free Survival | Estrogen Antagonists - therapeutic use | Tamoxifen - therapeutic use | Estrogen Antagonists - adverse effects | Tamoxifen - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Zoledronic acid | Care and treatment | Usage | Breast cancer | Health aspects | Function tests (Medicine) | Chemotherapy | Acids | Womens health | Menopause | Colorectal cancer | Cytotoxicity | Radiation therapy | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Drug-Induced Lipid Changes: A Review of the Unintended Effects of Some Commonly Used Drugs on Serum Lipid Levels
by Mantel-Teeuwisse A.K and Kloosterman J.M.E and Maitland-van der Zee A.H and Klungel O.H and Porsius A.J and de Boer A
2001, Volume 24, Issue 6, 14
Antihypertensives, adverse reactions | Celiprolol, adverse reactions | Retinol, adverse reactions | Diuretics, adverse reactions | Nelfinavir, adverse reactions | Phenytoin, adverse reactions | Retinoids, adverse reactions | Immunosuppressants, adverse reactions | Calcium channel antagonists, adverse reactions | Danazol, adverse reactions | Progestogens, adverse reactions | Hormonal replacements, adverse reactions | Raloxifene, adverse reactions | Phenobarbital, adverse reactions | Acitretin, adverse reactions | Tamoxifen, adverse reactions | Saquinavir, adverse reactions | Alpha adrenoceptor antagonists, adverse reactions | Carbamazepine, adverse reactions | Oral contraceptives, adverse reactions | Anticonvulsants, adverse reactions | Ritonavir, adverse reactions | Indinavir, adverse reactions | ACE inhibitors, adverse reactions | Estrogens, adverse reactions | Growth hormones, adverse reactions | Protease inhibitors, adverse reactions | Antipsychotics, adverse reactions | Clozapine, adverse reactions | Isotretinoin, adverse reactions | Lipid metabolism disorders, drug-induced | Valproic acid, adverse reactions | Beta adrenoceptor antagonists, adverse reactions | Medicine & Public Health | Drug Safety and Pharmacovigilance | Pharmacology/Toxicology | Pharmacology & Pharmacy | Public, Environmental & Occupational Health | Toxicology | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Medical sciences | Drug toxicity and drugs side effects treatment | Miscellaneous (drug allergy, mutagens, teratogens...) | Pharmacology. Drug treatments | Selective Estrogen Receptor Modulators - therapeutic use | Humans | Hormones - therapeutic use | Adult | Female | Immunosuppressive Agents - adverse effects | Male | Hormones - adverse effects | Cardiovascular Agents - adverse effects | Hyperlipidemias - chemically induced | Hyperlipidemias - prevention & control | immunosuppressive agents | contraceptives | anticonvulsants | dyslipidemia | diuretics | Index Medicus
Book Review
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women
by Torella, M and Del Deo, F and Grimaldi, A and Iervolino, S.A and Pezzella, M and Tammaro, C and Gallo, P and Rappa, C and De Franciscis, P and Colacurci, N
European journal of obstetrics & gynecology and reproductive biology, ISSN 0301-2115, 2016, Volume 207, pp. 125 - 128
Obstetrics and Gynecology | Urinary tract infections | Curcumin | Glycosaminoglycans | Quercetin | Estrogen | Life Sciences & Biomedicine | Obstetrics & Gynecology | Reproductive Biology | Science & Technology | Hyaluronic Acid - therapeutic use | Humans | Middle Aged | Secondary Prevention | Urinary Tract Infections - prevention & control | Vaginal Creams, Foams, and Jellies - adverse effects | Estrogens - adverse effects | Urinary Tract Infections - complications | Estrogens - therapeutic use | Vaginal Creams, Foams, and Jellies - therapeutic use | Chondroitin Sulfates - adverse effects | Anti-Infective Agents, Urinary - adverse effects | Aging | Anti-Infective Agents, Urinary - therapeutic use | Postmenopause | Female | Urinary Tract Infections - microbiology | Dietary Supplements - adverse effects | Hyaluronic Acid - adverse effects | Severity of Illness Index | Atrophic Vaginitis - physiopathology | Curcumin - therapeutic use | Quercetin - therapeutic use | Disease Resistance - drug effects | Curcumin - adverse effects | Chondroitin Sulfates - therapeutic use | Combined Modality Therapy - adverse effects | Atrophic Vaginitis - drug therapy | Estrogen Replacement Therapy - adverse effects | Antioxidants - therapeutic use | Estriol - adverse effects | Quercetin - adverse effects | Antioxidants - adverse effects | Estriol - therapeutic use | Urinary Tract Infections - urine | Atrophic Vaginitis - complications | Prevention | Relapse | Postmenopausal women | Sulfates | Hyaluronic acid | Chondroitin | Diseases | Evaluation | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Large-scale prediction and testing of drug activity on side-effect targets
by Lounkine, Eugen and Keiser, Michael J and Whitebread, Steven and Mikhailov, Dmitri and Hamon, Jacques and Jenkins, Jeremy L and Lavan, Paul and Weber, Eckhard and Doak, Allison K and Côté, Serge and Shoichet, Brian K and Urban, Laszlo
Nature (London), ISSN 0028-0836, 06/2012, Volume 486, Issue 7403, pp. 361 - 367
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Biological and medical sciences | Infectious diseases | Medical sciences | Animal viral diseases | Viral diseases | Drug Evaluation, Preclinical - methods | Molecular Targeted Therapy - adverse effects | Reproducibility of Results | Humans | Substrate Specificity | Forecasting | Cyclooxygenase Inhibitors - pharmacology | Models, Biological | Drug-Related Side Effects and Adverse Reactions | Chlorotrianisene - pharmacology | Chlorotrianisene - chemistry | Toxicity Tests - methods | Chlorotrianisene - adverse effects | Platelet Aggregation - drug effects | Cyclooxygenase 1 - metabolism | Estrogens, Non-Steroidal - adverse effects | Estrogens, Non-Steroidal - pharmacology | Blood Platelets - drug effects | Cyclooxygenase Inhibitors - adverse effects | Databases, Factual | Drugs | Adverse and side effects | Drug targeting | Diagnosis | Methods | Risk factors | Hypothesis testing | Ligands | Databases | Proprietary | Pharmaceutical industry | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Risk of venous thromboembolism among users of different anti-osteoporosis drugs : a population-based cohort analysis including over 200,000 participants from Spain and the UK
by Martín-Merino, E and Petersen, I and Hawley, S and Álvarez-Gutierrez, A and Khalid, S and Llorente-Garcia, A and Delmestri, A and Javaid, M K and Van Staa, T P and Judge, A and Cooper, C and Prieto-Alhambra, D
Osteoporosis international, ISSN 0937-941X, 02/2018, Volume 29, Issue 2, pp. 467 - 478
Humans | Middle Aged | Male | Diphosphonates/adverse effects | United Kingdom/epidemiology | Bone Density Conservation Agents/adverse effects | Teriparatide/adverse effects | Denosumab/adverse effects | Thiophenes/adverse effects | Aged, 80 and over | Female | Aged | Risk Assessment/methods | Primary Health Care/methods | Spain/epidemiology | Venous Thromboembolism/chemically induced | Alendronate/adverse effects | Cohort Studies | Pharmacoepidemiology | Anti-osteoporosis medication | Medicine & Public Health | Orthopedics | Rheumatology | Electronic health records | Primary care | Endocrinology | Venous thromboembolism | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Risk Assessment - methods | Primary Health Care - methods | Bone Density Conservation Agents - adverse effects | Thiophenes - adverse effects | Denosumab - adverse effects | Alendronate - adverse effects | Spain - epidemiology | Venous Thromboembolism - chemically induced | Teriparatide - adverse effects | Venous Thromboembolism - epidemiology | Diphosphonates - adverse effects | United Kingdom - epidemiology | Osteoporosis | Complications and side effects | Alendronate | Patient outcomes | Diphosphonates | Dosage and administration | Research | Drug therapy | Thromboembolism | Risk factors | Strontium | Alendronic acid | Parathyroid hormone | Estrogen receptors | Raloxifene | Health risk assessment | Bisphosphonates | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Adverse drug events associated with disorders of coagulation
by Barletta, Jeffrey F and Cooper, Brad and Ohlinger, Martin J
Critical care medicine, ISSN 0090-3493, 06/2010, Volume 38 Suppl, Identification and Prevention of Common Adverse Drug Events in the Intensive Care Unit, Issue 6, pp. S198 - S218
Critical illness | Thrombolytic | Prophylaxis | Reversal | Anticoagulation | Heparin | Low-molecular-weight heparin | Adverse drug event | Bleeding | Clotting | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Critical Care - methods | Blood Coagulation Disorders - chemically induced | Anti-Infective Agents - adverse effects | Humans | Thrombin - antagonists & inhibitors | Polysaccharides - adverse effects | Erythropoietin - adverse effects | Drug-Related Side Effects and Adverse Reactions - etiology | Antifibrinolytic Agents - adverse effects | Factor VIIa - adverse effects | Recombinant Proteins - adverse effects | Anticoagulants - adverse effects | Blood Coagulation Disorders - therapy | Deamino Arginine Vasopressin - adverse effects | Hemostatics - adverse effects | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Blood Coagulation Factors - adverse effects | Colloids - adverse effects | Thromboembolism - drug therapy | Estrogens, Conjugated (USP) - adverse effects | Drug-Related Side Effects and Adverse Reactions - therapy | Protein C - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights